What is the probability that a 5‑mm stone in the proximal ureter will pass spontaneously?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 27, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Likelihood of Spontaneous Passage for a 5mm Proximal Ureteral Stone

A 5mm stone in the proximal ureter has approximately a 48-65% chance of spontaneous passage, though this is significantly lower than distal stones and may take up to 4-6 weeks to pass.

Evidence-Based Probability

The likelihood of spontaneous passage for your specific scenario is influenced by two critical factors:

Stone Size (5mm)

  • 60-65% overall passage rate for 5mm stones across all ureteral locations 1, 2
  • This represents a critical threshold where passage rates begin to decline substantially
  • Stones ≤4mm pass at 76-81% rates, while stones ≥6mm drop to 33% or less 1, 2

Proximal Location (The Critical Factor)

  • Proximal ureteral stones pass at only 48% compared to 75-79% for distal stones 1
  • Location is as important as size in predicting passage 3
  • The more proximal the stone, the lower the chance of spontaneous passage 3, 4

Time Frame Expectations

If the stone does pass spontaneously, expect:

  • Mean passage time: 14.8-22.1 days for 4-6mm stones 3, 5
  • 95% of stones that will pass do so within 39-40 days 5
  • Cumulative passage rates: 55% by 7 days, 74% by 14 days, 89% by 28 days 3

Guideline-Based Management Approach

Medical Expulsive Therapy (MET)

Clinicians may offer alpha-blockers (tamsulosin, alfuzosin, silodosin) for approximately 30 days for proximal stones ≤10mm 6. However, the evidence is weaker for proximal stones than distal stones:

  • Meta-analysis showed no significant difference in spontaneous passage rates with MET for proximal ureteral stones 6
  • European guidelines suggest greatest benefit for stones >5mm in the distal ureter 7
  • This is a Conditional Recommendation (Grade B evidence) for proximal stones 6

Trial of Observation vs. Intervention

Given the 48-65% passage probability, a 30-day trial of spontaneous passage is reasonable if:

  • No signs of infection or sepsis
  • Adequate pain control is achievable
  • No significant hydronephrosis (Grade 3 hydronephrosis decreases passage likelihood) 4
  • Patient can tolerate observation

Factors That Worsen Your Prognosis

Be aware that passage likelihood decreases with:

  • Grade 3 hydronephrosis (vs Grade 1-2) 4
  • Presence of comorbidities 4
  • UTI without pyuria (due to luminal obstruction) 4
  • Stone density >1000 Hounsfield Units on CT 8

Common Pitfalls

  1. Don't wait indefinitely: If no passage by 4 weeks or no fragmentation evidence, proceed to intervention (ureteroscopy or SWL) 6
  2. Monitor for obstruction: Continued obstruction risks irreversible kidney function loss 6
  3. Watch for infection: Urgent decompression required if sepsis develops 7

Bottom Line Algorithm

For a 5mm proximal ureteral stone:

  1. Offer 30-day trial with alpha-blocker (knowing evidence is limited for proximal location)
  2. Counsel patient on ~50-65% passage probability
  3. If no passage by 30 days → proceed to ureteroscopy (preferred) or SWL
  4. If obstruction persists or infection develops → immediate intervention

The 50-50 odds mean shared decision-making is essential - some patients may prefer definitive treatment (ureteroscopy) upfront rather than waiting 4-6 weeks with uncertain outcome.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.